Composition of liquid cetrorelix.

CL202601016A1Pending Publication Date: 2026-07-31ARES TRADING SA

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202601016
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-10-03
Filing Date: 2026-04-01
Publication Date: 2026-07-31

Application Information

Patent Timeline

03 Oct 2024

Priority

01 Apr 2026

Application

CL202601016

31 Jul 2026

Publication

CL202601016A1

IPC: A61K38/09; A61K9/08; A61K47/10; A61K47/12; A61P15/08

CPC: A61K9/0019; A61K9/08; A61K47/10; A61K47/12; A61K38/09; A61P15/08; A61K47/26

Inventors: RINALDI Gianluca; PISTACCHIO Alessandra

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a liquid pharmaceutical composition of Cetrorelix comprising a stabilizing agent selected from poloxamer with an average molecular weight of 7,000 to 12,000 g / mol and / or benzyl alcohol, a pharmaceutical form comprising said liquid pharmaceutical composition, and its use for inhibiting premature luteinizing hormone surges in women undergoing controlled ovarian stimulation. A method for preparing the liquid pharmaceutical composition of Cetrorelix and the pharmaceutical form is also described.

Need to check novelty before this filing date? Find Prior Art